Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Treatment during development affects hormone balance and sexual behavior in male rats.

The study aims to find the best treatment for central serous chorioretinopathy by comparing various options.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.